Evaluation of different binders for roller compaction R. Wang, W. Liu, T. Durig

Similar documents
PHARMACEUTICAL TECHNOLOGY REPORT. Introduction. Experimental Methods

To study the effect that hydroxypropylcellulose (HPC) polymer molecular weight (MW) exerts on drug release rates and mechanism from matrix tablets.

PHARMACEUTICAL TECHNOLOGY REPORT. Abstract Summary. Introduction. Experimental Methods. Consumer Specialties ashland.com

Table 1 Hydrophilicity of MC and HPMC Grades. Polymer Cloud Point ( C) Hydrophilicity MC HPMC Type 2910 HPMC Type

Hydrodynamic Robustness of Hypromellose and Methylcellulose Based Modified Release Matrix Systems D. Tewari, R. K. Lewis, W. W. Harcum and T Dürig

Development of USP Delayed Release Aspirin Tablets using Opadry Enteric, Acrylic-Based Coating System

Direct Compression. With the right ingredients it s a simple, cost-effective manufacturing process

VIVAPHARM PVP/VA. Copovidone, Ph.Eur. USP/NF, JPE, E. The Ultimate Tablet Binder for All Processing Technologies

TECHNICAL INFORMATION RxCIPIENTS FM A versatile excipient for orally disintegrating tablet (ODT) formulations

STARCH Application Data

Primellose is an excellent choice as superdisintegrant in ODT applications

Evaluation of Moisture Sorption Methods for Aqueous Moisture Barrier Coatings D. Tewari, R. Lewis, B. Kinsey and T. Dürig*

FORMULATION AND EVALUATION OF PIROXICAM AND CELECOXIB TABLETS EMPLOYING PROSOLVE BY DIRECT COMPRESSION METHOD

Int. Res J Pharm. App Sci., 2014; 4(1):47-51 ISSN:

Short Communication. Formulation of Furosemide Dispersible Tablets for Use in Paediatrics V. V. ABWOVA, P. N. MBEO, L. J. TIROP AND K. A. M.

STABILITY STUDIES OF FORMULATED CONTROLLED RELEASE ACECLOFENAC TABLETS

Lactose Free, Direct Compression Formulation Used to Produce Loratadine (10 mg) Tablets

Formulation and Evaluation

Optimization of valsartan tablet formulation by 2 3 factorial design

DISSOLUTION ENHANCEMENT OF CARVEDILOL BY USING SURFACTANT AS A COATING MATERIAL

Asian Journal of Pharmacy and Life Science ISSN Vol. 2 (2), July-Sept,2012

FORMULATION AND EVALUATION OF VALSARTAN TABLETS EMPLOYING CYCLODEXTRIN-POLOXAMER 407-PVP K30 INCLUSION COMPLEXES

STUDIES ON EFFECT OF BINDERS ON ETORICOXIB TABLET FORMULATIONS

FORMULATION AND DEVELOPMENT OF ER METOPROLAOL SUCCINATE TABLETS

we ve got you covered pharmaceutical product and solution guide

Wherever life takes you BASF excipients for orally disintegrating tablets make medication easy

FLORITER. New Technology for Innovative Formulation Design.

A Comparative Evaluation of Cross Linked Starch Urea-A New Polymer and Other Known Polymers for Controlled Release of Diclofenac

Formulation and Evaluation of Rosuvastatin Immediate Release Tablets 10 Mg

Excipient Quality & Trouble Shooting. By Seema Trivedi GM, Technical

Technical brochure StarLac

PREPARATION AND INVITRO EVALUATION OF RABEPRAZOLE SODIUM DELAYED RELEASE ENTERIC COATED TABLETS

Sivakasi , Tamil Nadu, India. ABSTRACT KEYWORDS:

Etat des travaux du GDP

Wettable Magnesium Stearate. What Are Customers Looking for in Selecting Pharmaceutical Lubricants?

Int. Res J Pharm. App Sci., 2013; 3(6):42-46 ISSN:

Re-compaction properties of lactose and microcrystalline cellulose

LubriTose Mannitol Michael Crowley, Director of R&D, Excipients

Dextrol and Strodex Surfactant Selection Guide

EP B1 (19) (11) EP B1 (12) EUROPEAN PATENT SPECIFICATION

Formulation and In-vitro Evaluation of Chewable Tablets of Montelukast Sodium

Soluplus The Solid Solution Opening New Doors in Solubilization.

Scholars Research Library. Formulation Development of Pioglitazone Tablets Employing β Cyclodextrin- Poloxamer 407- PVP K30: A Factorial Study

IJRPC 2014, 4(2), Vinod Kumar et al. ISSN: INTERNATIONAL JOURNAL OF RESEARCH IN PHARMACY AND CHEMISTRY

Opadry Enteric. Application Data. Drug Release from Acrylic-Based Opadry Enteric (94 Series) Coated Tablets INTRODUCTION MATERIALS AND METHODS

Int. Res J Pharm. App Sci., 2012; 2(6): ISSN:

Critical material properties for the design of robust drug products : excipient functionality related characteristics

Easy, fast and reliable!

( 12 ) Patent Application Publication ( 10 ) Pub. No.: US 2017 / A1

DEVELOPMENT AND EVALUATION OF A DIRECTLY COMPRESSIBLE CO PROCESSED MULTIFUNCTION SUSTAINED RELEASE AGENT FOR TABLETS

FORMULATION AND EVALUATION OF THEOPHYLLINE BILAYERED TABLETS USING HPC AS MATRIX MATERIAL

Volker Bühler. Pharmaceutical Technology of BASF Excipients. Pharma Ingredients &Services. Welcome to more opportunities.

Karnataka Department of Pharmaceutical Technology, H.K.E. Society s College of Pharmacy, Gulbarga, Karnataka ABSTRACT KEYWORDS:

(51) Int Cl.: A61K 9/20 ( ) A61K 31/41 ( )

Research Paper The Effect of Different Superdisintegrants and their Concentrations on the Dissolution of Topiramate Immediate Release Tablets

xvi LIST OF TABLES S.NO Title of the Table Page No 2.1 Composition of zolmitriptan formulations Powder flow properties and angle of repose 58

The Relevance of USP Methodology in the Development of a Verapamil Hydrochloride (240 mg) Extended Release Formulation

FORMULATION AND EVALUATION OF ETORICOXIB TABLETS EMPLOYING CYCLODEXTRIN- POLOXAMER PVPK30 INCLUSION COMPLEXES

REGULATORY PERSPECTIVE. Dr. Raghunandan H V Associate Professor JSSCP, JSSU, Mysore

STARCH Proven and Trusted Excipient for Performance and Versatility EXCIPIENTS. Effective and economical disintegrant

372 J App Pharm Vol. 6; Issue 4: ; October, 2014 Moazzem et al, 2014

SCIENTIFIC DISCUSSION

EP A1 (19) (11) EP A1 (12) EUROPEAN PATENT APPLICATION. (43) Date of publication: Bulletin 2010/39

Formulation and Evaluation of Gastroretentive Dosage form of Ciprofloxacin Hydrochloride.

Formulation and Evaluation of Amlodipine besylate orally disintegrating tablet

Bioavailability enhancement of poorly soluble APIs. Enhanced solubilization out of solid glassy solutions prepared by Hot-Melt Extrusion

Formulation and evaluation of sublingual tablets of lisinopril

This PDF is available for free download from a site hosted by Medknow Publications

(12) Patent Application Publication (10) Pub. No.: US 2003/ A1

Journal of Chemical and Pharmaceutical Research

Design and development of fast Melting Tablets of Terbutaline Sulphate

Direct Compression Formulation Using Starch 1500 with Ranitidine HCl (150 mg) Tablets, Film Coated with Opadry II (85F Series)

Formulation and evaluation of oro-dispersible tablets of lafutidine

Formulation and evaluation of immediate release salbutamol sulphate

Formulation and In-vitro evaluation of immediate release Olanzapine tablets

Formulation Development and Evaluation of Atorvastatin Calcium Tablets using Co-Processed Excipients

Volume: 2: Issue-3: July-Sept ISSN FORMULATION AND EVALUATION OF SUSTAINED RELEASE MATRIX TABLETS OF NICORANDIL

J.Ayyappan et al, /J. Pharm. Sci. & Res. Vol.2 (7), 2010,

Formulation And Evaluation Of Flurbiprofen Matrix Tablets For Colon Targeting

The unlocked synergy of DFE Pharma MCC

Biswajit Biswal IRJP 2 (7)

FABRICATION AND EVALUATION OF GLIMEPIRIDE CORDIA DICHOTOMA G.FORST FRUIT MUCILAGE SUSTAINED RELEASE MATRIX TABLETS

Formulation Development of Nimesulide Tablets by Wet Granulation and Direct Compression Methods Employing Starch Citrate

Effect of Excipients on Dissolution: Case Studies with Bio-relevant/ Hydro-alcoholic Media

Formulation and Optimization of Immediate Release Tablet of Sitagliptin Phosphate using Response Surface Methodology

International Journal of Pharma and Bio Sciences FORMULATION AND EVALUATION OF TASTE MASKED DISPERSIBLE TABLETS OF ZIDOVUDINE YASH PAUL ABSTRACT

(51) Int Cl.: A61K 9/00 ( ) A61K 9/20 ( ) A61K 31/00 ( )

Effect of Compaction Forces on Powder Bed Permeability of Magnesium Silicate "Common Excipient Mixture"

Tablet is a major category of solid dosage forms which are widely used worldwide. Extensive information is required to prepare tablets with good

Formulation Development of Aceclofenac Tablets Employing Starch Phosphate -A New Modified Starch

IJRPC 2012, 2(3) Chowdary et al ISSN: INTERNATIONAL JOURNAL OF RESEARCH IN PHARMACY AND CHEMISTRY

(12) Patent Application Publication (10) Pub. No.: US 2008/ A1

Research Article. Chemical equivalence three brands of Aspirin sold in Sokoto State

CHAPTER 8 HYDROGEL PLUG FORMULATION AND EVAUATION

Research Article Formulation and In-Vitro Evaluation of Fast Disintegrating Rosiglitazone Sublingual Tablets

Formulation development of Glipizide matrix tablet using different proportion of natural and semi synthetic polymers

DVA Symposium Mexico City Anisul Quadir Ph.D, MBA SE Tylose USA, Inc. (A Shin-Etsu Chemical Group Co.) Totowa, NJ

PREPARATION AND EVALUATION OF STARCH - PEG 1500 CO-PROCESSED EXCIPIENT AS A NEW DIRECTLY COMPRESSIBLE VEHICLE IN TABLET FORMULATIONS

Narrowing the gap between clinical capsule formulations and commercial film-coated tablets

Transcription:

PHARMACEUTICAL THNOLOGY REPORT Consumer Specialties ashland.com PTR 11 Page 1 of 5 Evaluation of different binders for roller compaction R. Wang, W. Liu, T. Durig Objectives When preparing tablets by roller compaction, managing compactability and friability can be challenging due to the double compression process. Binders are critical functional ingredients in tablets prepared by roller compaction. This study compares binder performance in tablets prepared by roller compaction. Introduction Roller compaction is an economical granulation technology that requires fewer processing steps and less processing equipment than wet granulation. Roller compaction can improve flow and density properties that are often lacking in direct compression formulations. It is a good alternative to wet granulation for formulations that have poor flowability. As no water or solvent is added to ingredients, roller compaction is also suitable for APIs that are sensitive to moisture. There are two challenges, however, in preparing tablets by roller compaction; namely compactability and friability, which are adversely impacted by the double compression process. This study evaluates the performance of different binders: hydroxypropylcellulose (Klucel EXF ), copovidone (Plasdone S-63 /VA), hypromellose (Benecel E15 ), povidone (Plasdone K-29/32 ) and ethylcellulose (Aqualon T1 ), in tablets prepared by roller compaction. Metformin HCl and acetaminophen, which are poorly flowable and poorly compactable, were chosen as model drugs in this study. Experimental methods Mixtures of 75.8% metformin, different levels of binder (% or 6%) and mannitol (see Table 1) were roller compacted at a roll pressure of bar (TFG LAB Micro; Freund-Vector Corporation, USA) and then milled, lubricated with magnesium stearate and compressed to 6 mg tablets (8 station, Mini press II; Karnavati Engineering, India) under different compaction forces (1, 15, 2, 25 kn). Table 1. Metformin formulations % binder 6% binder Ingredients mg/tablet % mg/tablet % Metformin HCl 5 75.8 5 75.8 Mannitol 157 23.8 117.4 17.8 Binder * 39.6 6 Mg stearate 3.4 3.4 Total 6 1 6 1 Note: This work was presented at the annual meeting of the American Association of Pharmaceutical Scientists, October 25 29, 215, Orlando, Florida. All statements, information and data presented herein are believed to be accurate and reliable, but are not to be taken as a guarantee, an express warranty, or an implied warranty of merchantability or fitness for a particular purpose, or representation, express or implied, for which Ashland and its subsidiaries assume legal responsibility. Registered trademark, Ashland or its subsidiaries, registered in various countries. Trademark, Ashland or its subsidiaries, registered in various countries. *Trademark owned by a third party. 216, Ashland. 2-216

Page 2 of 5 Additionally, mixtures of % acetaminophen, different levels of binder (% or 6%), mannitol, Polyplasdone XL crospovidone (P) and.3% silicon dioxide (see Table 2) were roller compacted at a roll pressure of bar and then milled with the other.3% silicon dioxide; lubricated with magnesium stearate, stearate acid and talc and compressed to 5 mg tablets under different compaction forces. % binder 6% binder Ingredients mg/tablet % mg/tablet % Acetaminophen 3 3 Mannitol 164 32.8 134 26.8 Binder * 3 6 Polyplasdone XL crospovidone 15 3 15 3 Silicon dioxide 3.6 3.6 Talcum 1 2 1 2 Magnesium stearate 4.8 4.8 Stearic acid 4.8 4.8 Total 5 mg 1% 5 mg 1% Breaking force: Breaking force of tablets made with different binders and compaction forces were evaluated using a TBH 3MD (Erweka GmbH, Germany). Tablet friability: Friability was evaluated using a Tar2 friability tester (Erweka GmbH, Germany). Dissolution: All dissolution testing was conducted using tablets that were compressed with 2 kn force. Dissolution of metformin tablets was conducted using 1 ml of ph 6.8 phosphate buffer media with USP Apparatus II at 5 rpm. Dissolution of APAP tablets was conducted using 9 ml of ph 5.8 phosphate buffer media with USP Apparatus II at 5 rpm. Samples were taken at 5, 1, 15, 3 and 45 min and evaluated with UV-Vis. Materials Metformin HCl, CP, Shouguang Fukang Pharmaceutical Co. Ltd, Shandong Province, China Acetaminophen, CP, Hebei Jiheng (Group) Pharmaceutical Co. Ltd, Hebei Province, China Klucel EXF hydroxypropylcellulose (); Plasdone S-63 copovidone (/VA); Benecel E15 hypromellose (); Plasdone K-29/32 povidone (); Aqualon T1 ethylcellulose () and Polyplasdone crospovidone (P) all marketed by Ashland Inc., USA. Mannitol: Pearlitol SD2, Roquette Inc., France Results and Discussion Klucel EXF provided better compactability than other binders for both metformin and acetaminophen formulations (see Figures 1 and 2). For acetaminophen formulations, Plasdone S-63 /VA also performed very well. The effect of roll pressure was studied for acetaminophen tablets with 6% of Klucel EXF or Plasdone S-63 /VA (see Figure 3). Increasing roll pressure from 5 bar to 7 bar has little effect on compactability of the acetaminophen formulation with Plasdone S-63 /VA in this study. For Klucel EXF, lower roll pressure achieved higher tablet breaking forces.

Page 3 of 5 Tablet breaking force (N) 2 /VA 5 1 15 2 25 Figure 1. Tablet breaking force of metformin formulations with % or 6% binder 11 1 Tablet breaking force (N) 9 8 7 /VA 5 5 1 15 2 25 3 Figure 2. Tablet breaking force of acetaminophen formulations with % or 6% binder 11 Tablet hardness (N) 1 9 8 7 5 bar bar 7 bar /VA 5 bar /VA bar /VA 7 bar 5 5 1 15 2 25 Figure 3. Tablet breaking force of acetaminophen formulations with or /VA at various roll pressure

Page 4 of 5 As seen in Figures 4 and 5, Klucel EXF provided the lowest friability for both metformin and acetaminophen formulations. No capping occurred during friability testing with Klucel EXF in formulations compressed at 1 25 kn. For other binders, capping occurred during friability testing for tablets compressed at very low or very high compression forces. 15 1 kn Friability(%) 1 15 kn 2 kn 25 kn 5 /VA Fig 4 Friability of Metformin formulations with % or 6% binder 3 1 kn Friability (%) 2 15 kn 2 kn 25 kn 1 /VA Fig 5. Friability of acetaminophen formulations with % or 6% binder The dissolution results for metformin tablets and acetaminophen tablets with different binders were all acceptable and similar to one another (see Figures 6 and 7).

Page 5 of 5 1 8 Tolerance (Q) line Drug realese (%) 2 /VA 1 2 3 5 Time (min) Fig 6. Dissolution of metformin formulations with % or 6% binder 1 8 Tolerance (Q) line Drug release (%) 2 /VA 1 2 3 5 Time (min) Fig 7. Dissolution of acetaminophen formulations with % or 6% binder Conclusions Klucel EXF is a very effective binder for roller compaction, which provides consistently higher tablet strength and lower friability than many other binders. No capping occurred during tablet compaction and friability testing for formulations including Klucel EXF.